{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:24:18Z","timestamp":1785223458591,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":136,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Pharmacology and Drug Discovery"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.crphar.2022.100111","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T01:47:14Z","timestamp":1653097634000},"page":"100111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Three-dimensional spheroids of choroid-retinal vascular endothelial cells as an in-vitro model for diabetic retinopathy: Proof-of-concept investigation"],"prefix":"10.1016","volume":"3","author":[{"given":"Manish","family":"Gore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devashree","family":"Jahagirdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angayarkanni","family":"Narayanasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratnesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5968-1072","authenticated-orcid":false,"given":"Prajakta","family":"Dandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crphar.2022.100111_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fphys.2017.00605","article-title":"Comparative analysis of 3D bladder tumor spheroids obtained by forced floating and hanging drop methods for drug screening","volume":"8","author":"Amaral","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.crphar.2022.100111_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/584238","article-title":"Intravitreal bevacizumab (avastin) for diabetic retinopathy: the 2010 GLADAOF lecture","author":"Arevalo","year":"2011","journal-title":"J.\u00a0Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000455277","article-title":"Diabetic macular edema","volume":"58","author":"Bandello","year":"2017","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010109","article-title":"The inhibitory effects of gold nanoparticles on VEGF-A-induced cell migration in choroid-retina endothelial cells","volume":"21","author":"Chan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crphar.2022.100111_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3892\/etm.2021.9820","article-title":"Visfatin promotes angiogenesis of RF\/6A cells through upregulation of VEGF\/VEGFR-2 under high-glucose conditions","volume":"21","author":"Chen","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.crphar.2022.100111_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157339909787314149","article-title":"Diabetic retinopathy and angiogenesis","volume":"5","author":"Crawford","year":"2009","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.crphar.2022.100111_bib7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjophthalmol-2012-301677","article-title":"Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences","volume":"96","author":"Deissler","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.crphar.2022.100111_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/aos.14377","article-title":"Evidence and indications for systemic treatment in diabetic retinopathy: a systematic review","volume":"98","author":"Elkjaer","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4161\/org.4.4.7414","article-title":"VEGF and endothelial guidance in angiogenic sprouting","volume":"4","author":"Gerhardt","year":"2008","journal-title":"Organogenesis"},{"key":"10.1016\/j.crphar.2022.100111_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.mvr.2007.05.006","article-title":"In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents","volume":"74","author":"Goodwin","year":"2007","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.crphar.2022.100111_bib12","series-title":"Drug Delivery for the Retina and Posterior Segment Disease","first-page":"83","article-title":"Diabetic Retinopathy: Pathogenesis, Treatment, and Complications","author":"Gudla","year":"2018"},{"key":"10.1016\/j.crphar.2022.100111_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fendo.2020.00591","article-title":"Endothelial dysfunction in diabetic retinopathy","volume":"11","author":"Gui","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.crphar.2022.100111_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110999","article-title":"Capilliposide B blocks VEGF-induced angiogenesis in vitro in primary human retinal microvascular endothelial cells","volume":"133","author":"Han","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.crphar.2022.100111_bib15","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1096\/fj.14-267633","article-title":"Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro","volume":"29","author":"Heiss","year":"2015","journal-title":"Faseb. J. : Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.crphar.2022.100111_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9080712","article-title":"Protective effect of fenofibrate on oxidative stress-induced apoptosis in retinal-choroidal vascular endothelial cells: implication for diabetic retinopathy treatment","volume":"9","author":"Hsu","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.crphar.2022.100111_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11010-013-1710-y","article-title":"Vascular endothelial growth factor regulates primate choroid-retinal endothelial cell proliferation and tube formation through PI3K\/Akt and MEK\/ERK dependent signaling","volume":"381","author":"Jin","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.crphar.2022.100111_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000500026","article-title":"Pathophysiology of diabetic retinopathy: contribution and limitations of laboratory research","volume":"62","author":"Kern","year":"2019","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.crphar.2022.100111_bib20","article-title":"Animal models of diabetic retinopathy: summary and comparison","volume":"2013","author":"Lai","year":"2013","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.crphar.2022.100111_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.18502\/jovr.v15i3.7453","article-title":"Safety of intravitreal injection of stivant, a biosimilar to bevacizumab, in rabbit eyes","volume":"15","author":"Lashay","year":"2020","journal-title":"J.\u00a0Ophthalmic Vis. Res."},{"key":"10.1016\/j.crphar.2022.100111_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bcp.2019.07.021","article-title":"Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF\/ERK pathway","volume":"168","author":"Lazzara","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.crphar.2022.100111_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1039\/C4BM00319E","article-title":"Media additives to promote spheroid circularity and compactness in hanging drop platform","volume":"3","author":"Leung","year":"2015","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.crphar.2022.100111_bib24","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3892\/etm.2017.4651","article-title":"Occludin downregulation in high glucose is regulated by SSTR(2) via the VEGF\/NRP1\/Akt signaling pathway in RF\/6A cells","volume":"14","author":"Li","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.crphar.2022.100111_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155541","article-title":"Chrysin inhibits high glucose-induced migration on chorioretinal endothelial cells via VEGF and VEGFR down-regulation","volume":"21","author":"Liao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crphar.2022.100111_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","article-title":"Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy","volume":"164","author":"Mehta","year":"2012","journal-title":"J.\u00a0Contr. Release : Off. J. Control. Release Soc."},{"key":"10.1016\/j.crphar.2022.100111_bib27","article-title":"A\u00a0critical analysis of the available in vitro and ex vivo methods to study retinal angiogenesis","volume":"2017","author":"Moleiro","year":"2017","journal-title":"J.\u00a0Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib28","first-page":"15","article-title":"Inhibition of proliferation of retinal vascular endothelial cells more effectively than choroidal vascular endothelial cell proliferation by bevacizumab","volume":"10","author":"Mynampati","year":"2017","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11892-017-0913-0","article-title":"Animal models of diabetic retinopathy","volume":"17","author":"Olivares","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.crphar.2022.100111_bib30","first-page":"999","article-title":"Effects of two different doses of intravitreal bevacizumab on subfoveal choroidal thickness and retinal vessel diameter in branch retinal vein occlusion","volume":"9","author":"Park","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177737","article-title":"Cancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers","volume":"12","author":"Pereira","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.crphar.2022.100111_bib32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bjo.2006.109702","article-title":"Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells","volume":"91","author":"Peters","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10456-013-9398-x","article-title":"In vitro and ex vivo retina angiogenesis assays","volume":"17","author":"Rezzola","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.crphar.2022.100111_bib34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10456-017-9575-4","article-title":"3D endothelial cell spheroid\/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy","volume":"20","author":"Rezzola","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.crphar.2022.100111_bib35","first-page":"3339","article-title":"Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells","volume":"17","author":"Rusovici","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.crphar.2022.100111_bib36","first-page":"321","article-title":"Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle","volume":"7","author":"Rusovici","year":"2013","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.crphar.2022.100111_bib38","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jconrel.2020.10.054","article-title":"Nanodiagnostics and Nanotherapeutics for age-related macular degeneration","volume":"329","author":"Sarkar","year":"2021","journal-title":"J.\u00a0Contr. Release : Off. J. Control. Release Soc."},{"key":"10.1016\/j.crphar.2022.100111_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/582060","article-title":"Diabetic retinopathy: vascular and inflammatory disease","author":"Semeraro","year":"2015","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.crphar.2022.100111_bib40","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/bjo.2006.095190","article-title":"Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells","volume":"90","author":"Spitzer","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.crphar.2022.100111_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000622","article-title":"The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling","volume":"5","author":"Stefanini","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.crphar.2022.100111_bib42","doi-asserted-by":"crossref","first-page":"e2995","DOI":"10.21769\/BioProtoc.2995","article-title":"Human endothelial cell spheroid-based sprouting angiogenesis assay in collagen","volume":"8","author":"Tetzlaff","year":"2018","journal-title":"Bio-protocol"},{"key":"10.1016\/j.crphar.2022.100111_bib43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","article-title":"Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.crphar.2022.100111_bib44","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crphar.2022.100111_bib45","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00424-020-02432-y","article-title":"MiR-221-3p regulates the microvascular dysfunction in diabetic retinopathy by targeting TIMP3","volume":"472","author":"Wang","year":"2020","journal-title":"Pflueg. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.crphar.2022.100111_bib46","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/14712598.2018.1545836","article-title":"Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies","volume":"18","author":"Whitehead","year":"2018","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.crphar.2022.100111_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000502387","article-title":"Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence","volume":"243","author":"Wong","year":"2020","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.crphar.2022.100111_bib48","first-page":"1982","article-title":"A\u00a0novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo","volume":"16","author":"Xu","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.crphar.2022.100111_bib49","article-title":"Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1\/2-regulated HIF-1\u03b1-VEGF\/VEGFR2 signaling pathway","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crphar.2022.100111_bib50","doi-asserted-by":"crossref","first-page":"H135","DOI":"10.1530\/VB-19-0026","article-title":"New artery of knowledge: 3D models of angiogenesis","volume":"1","author":"Zucchelli","year":"2019","journal-title":"Vasc. Biol."}],"container-title":["Current Research in Pharmacology and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257122000311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257122000311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:53:14Z","timestamp":1762923194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590257122000311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":49,"alternative-id":["S2590257122000311"],"URL":"https:\/\/doi.org\/10.1016\/j.crphar.2022.100111","relation":{},"ISSN":["2590-2571"],"issn-type":[{"value":"2590-2571","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-dimensional spheroids of choroid-retinal vascular endothelial cells as an in-vitro model for diabetic retinopathy: Proof-of-concept investigation","name":"articletitle","label":"Article Title"},{"value":"Current Research in Pharmacology and Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphar.2022.100111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100111"}}